Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib for Refractory Malignant Ascites
NCT00796861Phase 2Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- May 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in malignant ascites, sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Overall Response Rate. Started May 2007; status: terminated.
02
Drugs
sunitinib
03
Conditions
malignant ascites
Beyond the preview
Go deeper on NCT00796861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796861.